FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Douglas Robert Andrew
2. Issuer Name and Ticker or Trading Symbol

RESMED INC [ RMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President and COO ResMed Inc.
(Last)          (First)          (Middle)

RESMED INC., 9001 SPECTRUM CENTER BLVD.
3. Date of Earliest Transaction (MM/DD/YYYY)

4/1/2015
(Street)

SAN DIEGO, CA 92123
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
ResMed Common Stock   4/1/2015     S (1)    500   D $71.96   57620.354   I   Douglas Family Trust  
ResMed Common Stock   4/1/2015     M (1)    5833   A $19.25   63503.354   I   Douglas Family Trust  
ResMed Common Stock   4/1/2015     S (1)    5833   D $70.56   (3) 58120.354   I   Douglas Family Trust  
ResMed Common Stock                  42662   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed Common Stock Options   $19.25   4/1/2015     M   (1)       5833    2/3/2007   (2) 2/3/2016   ResMed Common Stock   5833   $0   52451   I   Douglas Family Trust  

Explanation of Responses:
( 1)  The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
( 2)  Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.
( 3)  This transaction was executed in multiple trades at prices ranging from $70.12-$70.78. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Douglas Robert Andrew
RESMED INC.
9001 SPECTRUM CENTER BLVD.
SAN DIEGO, CA 92123


President and COO ResMed Inc.

Signatures
Robert Douglas, President and Chief Operating Officer, ResMed Inc. 4/3/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ResMed (NYSE:RMD)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more ResMed Charts.
ResMed (NYSE:RMD)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more ResMed Charts.